LV10960B - Process for preparation of intermediate products - Google Patents
Process for preparation of intermediate products Download PDFInfo
- Publication number
- LV10960B LV10960B LVP-93-818A LV930818A LV10960B LV 10960 B LV10960 B LV 10960B LV 930818 A LV930818 A LV 930818A LV 10960 B LV10960 B LV 10960B
- Authority
- LV
- Latvia
- Prior art keywords
- hjih
- quot
- mji
- hydrogen
- okch
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 4
- 239000013067 intermediate product Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 10
- 239000001257 hydrogen Substances 0.000 claims abstract 10
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract 4
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims abstract 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract 4
- 229910052794 bromium Inorganic materials 0.000 claims abstract 4
- 229910052801 chlorine Inorganic materials 0.000 claims abstract 4
- 239000000460 chlorine Substances 0.000 claims abstract 4
- 229910052731 fluorine Inorganic materials 0.000 claims abstract 4
- 239000011737 fluorine Substances 0.000 claims abstract 4
- 229920006395 saturated elastomer Polymers 0.000 claims abstract 3
- 230000002378 acidificating effect Effects 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- -1 nitro, carboxy Chemical group 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- 235000015320 potassium carbonate Nutrition 0.000 description 3
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- 101150096418 Mepe gene Proteins 0.000 description 2
- 241000269435 Rana <genus> Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- AUZONCFQVSMFAP-UHFFFAOYSA-N disulfiram Chemical compound CCN(CC)C(=S)SSC(=S)N(CC)CC AUZONCFQVSMFAP-UHFFFAOYSA-N 0.000 description 2
- XWPCYYOZOJKYKQ-UHFFFAOYSA-N 1-(2-chloroethyl)-3-[2-[2-[[2-chloroethyl(nitroso)carbamoyl]amino]ethyldisulfanyl]ethyl]-1-nitrosourea Chemical compound ClCCN(N=O)C(=O)NCCSSCCNC(=O)N(N=O)CCCl XWPCYYOZOJKYKQ-UHFFFAOYSA-N 0.000 description 1
- PTHLSIBOMNYSIS-UHFFFAOYSA-N 5-(4-aminophenyl)-8-chloro-3-methyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol Chemical compound C1N(C)CCC2=CC(Cl)=C(O)C=C2C1C1=CC=C(N)C=C1 PTHLSIBOMNYSIS-UHFFFAOYSA-N 0.000 description 1
- 241000191291 Abies alba Species 0.000 description 1
- 101100397240 Arabidopsis thaliana ISPD gene Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102100035861 Cytosolic 5'-nucleotidase 1A Human genes 0.000 description 1
- 101000802744 Homo sapiens Cytosolic 5'-nucleotidase 1A Proteins 0.000 description 1
- 241001026509 Kata Species 0.000 description 1
- 241000087799 Koma Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Fats And Perfumes (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Threshing Machine Elements (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8501693A SE8501693D0 (sv) | 1985-04-04 | 1985-04-04 | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10960A LV10960A (lv) | 1995-12-20 |
| LV10960B true LV10960B (en) | 1996-08-20 |
Family
ID=20359775
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-818A LV10960B (en) | 1985-04-04 | 1993-06-30 | Process for preparation of intermediate products |
| LVP-93-861A LV10281B (en) | 1985-04-04 | 1993-06-30 | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
| LVP-93-1006A LV10957B (en) | 1985-04-04 | 1993-07-30 | 16 alpha, 17alpha-acetalsubstituted androstan-17betha-carboxyl acid esters, method of their preparation, intermediates, method of their producing, pharmaceutical compositions |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-861A LV10281B (en) | 1985-04-04 | 1993-06-30 | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
| LVP-93-1006A LV10957B (en) | 1985-04-04 | 1993-07-30 | 16 alpha, 17alpha-acetalsubstituted androstan-17betha-carboxyl acid esters, method of their preparation, intermediates, method of their producing, pharmaceutical compositions |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4950659A (cs) |
| EP (2) | EP0355859B1 (cs) |
| JP (1) | JPH0762028B2 (cs) |
| KR (1) | KR930009444B1 (cs) |
| CN (1) | CN1021444C (cs) |
| AT (2) | ATE107657T1 (cs) |
| AU (1) | AU590545B2 (cs) |
| CA (1) | CA1333597C (cs) |
| CS (1) | CS266581B2 (cs) |
| DD (2) | DD247681A5 (cs) |
| DE (2) | DE3689936T2 (cs) |
| DK (3) | DK165638C (cs) |
| ES (2) | ES8800264A1 (cs) |
| FI (1) | FI85378C (cs) |
| GR (1) | GR860902B (cs) |
| HU (2) | HU196830B (cs) |
| IE (1) | IE61474B1 (cs) |
| IL (1) | IL78143A0 (cs) |
| JO (1) | JO1479B1 (cs) |
| LT (3) | LT3812B (cs) |
| LV (3) | LV10960B (cs) |
| MY (1) | MY102056A (cs) |
| NO (1) | NO165298C (cs) |
| NZ (1) | NZ215586A (cs) |
| PH (2) | PH23547A (cs) |
| PL (2) | PL150052B1 (cs) |
| PT (1) | PT82340B (cs) |
| RU (3) | RU1795972C (cs) |
| SE (1) | SE8501693D0 (cs) |
| UA (2) | UA13319A (cs) |
| ZA (1) | ZA861884B (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8501693D0 (sv) | 1985-04-04 | 1985-04-04 | Draco Ab | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
| HU203769B (en) * | 1989-03-09 | 1991-09-30 | Richter Gedeon Vegyeszet | Process for producing new steroide derivatives and pharmaceutical compositions containing them |
| AU672669B2 (en) * | 1992-12-24 | 1996-10-10 | Rhone-Poulenc Rorer Limited | New steroids |
| GB9423919D0 (en) * | 1994-11-26 | 1995-01-11 | Rhone Poulenc Rorer Ltd | Chemical process |
| GB0110411D0 (en) * | 2001-04-27 | 2001-06-20 | Astrazeneca Ab | Chemical process |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3828080A (en) * | 1972-01-20 | 1974-08-06 | Glaxo Lab Ltd | Androstane-17beta-carboxylic acids and processes for the preparation thereof |
| SE378109B (cs) * | 1972-05-19 | 1975-08-18 | Bofors Ab | |
| GB1438940A (en) * | 1972-07-19 | 1976-06-09 | Glaxo Lab Ltd | 17beta-haloalkoxycarbonyl-17alpha-oxysteroids |
| GB1517278A (en) * | 1974-08-30 | 1978-07-12 | Glaxo Lab Ltd | Alkyl and haloalkyl androsta-1,4,15-triene and-4,15-diene-17beta-carboxylates |
| CH628355A5 (de) * | 1976-02-24 | 1982-02-26 | Ciba Geigy Ag | Verfahren zur herstellung neuer androstadien-17beta-carbonsaeuren und ihrer ester und salze. |
| US4198336A (en) * | 1978-04-05 | 1980-04-15 | Syntex (U.S.A.) Inc. | Chemical process for preparing androsta-4-ene 17α-carboxylic acids |
| ZA814440B (en) * | 1980-07-10 | 1982-10-27 | Otsuka Pharma Co Ltd | Soft steroids having anti-inflammatory activity |
| SE449106B (sv) * | 1980-07-10 | 1987-04-06 | Otsuka Pharma Co Ltd | Steroid med anti-inflammatorisk verkan samt komposition innehallande denna |
| ZA817929B (en) * | 1980-12-22 | 1982-10-27 | Upjohn Co | 5alpha-and 5beta-androstane-17beta-carboxylates |
| SE8306370D0 (sv) * | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
| SE8403905D0 (sv) * | 1984-07-30 | 1984-07-30 | Draco Ab | Liposomes and steroid esters |
| SE8501693D0 (sv) | 1985-04-04 | 1985-04-04 | Draco Ab | Novel 16,17-acetalsubstituted androstane-17beta-carboxylic acid esters |
| JP2687768B2 (ja) * | 1991-07-30 | 1997-12-08 | トヨタ自動車株式会社 | エンジンの制御装置 |
-
1985
- 1985-04-04 SE SE8501693A patent/SE8501693D0/xx unknown
-
1986
- 1986-03-13 ZA ZA861884A patent/ZA861884B/xx unknown
- 1986-03-14 IL IL78143A patent/IL78143A0/xx not_active IP Right Cessation
- 1986-03-19 AU AU54868/86A patent/AU590545B2/en not_active Expired
- 1986-03-21 EP EP89116726A patent/EP0355859B1/en not_active Expired - Lifetime
- 1986-03-21 DE DE3689936T patent/DE3689936T2/de not_active Expired - Lifetime
- 1986-03-21 AT AT89116726T patent/ATE107657T1/de not_active IP Right Cessation
- 1986-03-21 AT AT86850103T patent/ATE83241T1/de not_active IP Right Cessation
- 1986-03-21 DE DE8686850103T patent/DE3687239T2/de not_active Expired - Lifetime
- 1986-03-21 EP EP86850103A patent/EP0197018B1/en not_active Expired - Lifetime
- 1986-03-25 NZ NZ215586A patent/NZ215586A/en unknown
- 1986-03-25 US US06/843,771 patent/US4950659A/en not_active Expired - Lifetime
- 1986-03-25 FI FI861275A patent/FI85378C/fi not_active IP Right Cessation
- 1986-03-25 DK DK138386A patent/DK165638C/da not_active IP Right Cessation
- 1986-04-01 JO JO19861479A patent/JO1479B1/en active
- 1986-04-02 CS CS862328A patent/CS266581B2/cs unknown
- 1986-04-03 UA UA4027252A patent/UA13319A/uk unknown
- 1986-04-03 CA CA000505744A patent/CA1333597C/en not_active Expired - Fee Related
- 1986-04-03 NO NO861313A patent/NO165298C/no unknown
- 1986-04-03 DD DD86288744A patent/DD247681A5/de unknown
- 1986-04-03 UA UA4027897A patent/UA19288A/uk unknown
- 1986-04-03 RU SU864027252A patent/RU1795972C/ru active
- 1986-04-03 HU HU861423A patent/HU196830B/hu not_active IP Right Cessation
- 1986-04-03 KR KR1019860002523A patent/KR930009444B1/ko not_active Expired - Lifetime
- 1986-04-03 IE IE87986A patent/IE61474B1/en not_active IP Right Cessation
- 1986-04-03 ES ES553675A patent/ES8800264A1/es not_active Expired
- 1986-04-03 JP JP61075677A patent/JPH0762028B2/ja not_active Expired - Lifetime
- 1986-04-03 HU HU884925A patent/HU199872B/hu unknown
- 1986-04-04 PL PL1986265699A patent/PL150052B1/pl unknown
- 1986-04-04 GR GR860902A patent/GR860902B/el unknown
- 1986-04-04 CN CN86102193A patent/CN1021444C/zh not_active Expired - Fee Related
- 1986-04-04 PT PT82340A patent/PT82340B/pt unknown
- 1986-04-04 PL PL1986258775A patent/PL148272B1/pl unknown
- 1986-07-31 RU SU864027897A patent/RU1779257C/ru active
-
1987
- 1987-01-14 ES ES557314A patent/ES8802392A1/es not_active Expired
- 1987-07-31 PH PH35610A patent/PH23547A/en unknown
- 1987-07-31 DD DD87305598A patent/DD261364A5/de unknown
- 1987-09-28 MY MYPI87001991A patent/MY102056A/en unknown
-
1988
- 1988-06-13 PH PH37057A patent/PH24369A/en unknown
-
1991
- 1991-11-05 RU SU915001895A patent/RU2081879C1/ru active
-
1992
- 1992-05-05 DK DK059392A patent/DK167150B1/da not_active IP Right Cessation
-
1993
- 1993-05-21 DK DK059693A patent/DK167574B1/da not_active IP Right Cessation
- 1993-06-30 LV LVP-93-818A patent/LV10960B/lv unknown
- 1993-06-30 LV LVP-93-861A patent/LV10281B/xx unknown
- 1993-07-30 LV LVP-93-1006A patent/LV10957B/lv unknown
- 1993-12-28 LT LTIP1677A patent/LT3812B/lt not_active IP Right Cessation
- 1993-12-28 LT LTIP1678A patent/LT3913B/lt not_active IP Right Cessation
- 1993-12-28 LT LTIP1676A patent/LT3811B/lt not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016110718A (ru) | Композиции, содержащие фторзамещенные олефины | |
| NZ744349A (en) | Pyrazolo[1,5-a]pyrazin-4-yl derivatives as jak-inhibitors | |
| SI3880676T1 (sl) | Derivati 2,3-dihidro-1h-pirolo(3,4-c)piridin-1-ona kot zaviralci hpk1 za zdravljenje raka | |
| WO2017223452A1 (en) | Degradation of bromodomain-containing protein 9 (brd9) by conjugation of brd9 inhibitors with e3 ligase ligand and methods of use | |
| EP4072548A4 (en) | COMPOSITIONS AND METHODS FOR SUBSTITUTED 7-(PIPERAZINE-1-YL)PYRAZOLO[ 1,5-A]PYRIMIDINE ANALOGUES AS INHIBITORS BY KRAS | |
| LV10960B (en) | Process for preparation of intermediate products | |
| WO2010143168A3 (en) | Compounds useful for treating cancer | |
| IL289933A (en) | History of 7,6-dihydro-5h-pyrido[3,2-c]pyridazine and related compounds as bcl-xl protein inhibitors and pro-apoptotic agents for cancer therapy | |
| HK1258996A1 (zh) | 新型fyn激酶抑制剂的方法、组合物以及用途 | |
| Jaime-Figueroa et al. | Discovery of a series of novel 5H-pyrrolo [2, 3-b] pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors | |
| MX2025010149A (es) | [1,3]tiazolo[4,5-d]-pirimidin-7-onas como inhibidores de la nox4 | |
| MX2021002051A (es) | Imidazo[1,2-b]piridaziinas como inhibidores de trk. | |
| PE20191236A1 (es) | Compuestos de pirazolopirimidina y metodos de uso de los mismos | |
| EP3852792A1 (en) | Inhibiting ubiquitin specific peptidase 9x | |
| MX2021000096A (es) | Espuma de poliuretano o poliol de polieter estabilizados con un derivado de benzofuranona-fosfito. | |
| MX2022009884A (es) | Compuestos de 7-(metilamino)pirazolo[1,5-a]pirimidin-3-carboxamida . | |
| MX2023009379A (es) | Derivados de tetrahidroazepina biciclicos para el tratamiento del cancer. | |
| PH12018501489A1 (en) | Compounds and compositions for the treatment of cryptosporidiosis | |
| EP3902533A1 (en) | Inhibiting ubiquitin specific peptidase 9x | |
| CZ292092B6 (cs) | Deriváty triazolopyrimidinu | |
| JP2012526146A (ja) | ヒドロフルオロオレフィン生成においてモノフルオロ酢酸塩の量を低減する方法 | |
| MX2021000683A (es) | Derivados de imidazo[1,2-b]piridazina como inhibidores de trk. | |
| MY201313A (en) | Improved method for the manufacture of 3-[(1s)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof | |
| ES8505684A1 (es) | Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas | |
| PH12021553139A1 (en) | Novel carbonate compound having pyrrolopyrimidine skeleton or pharmaceutically acceptable salt thereof |